Literature DB >> 11948877

Chemoenzymatic synthesis of biotinylated nucleotide sugars as substrates for glycosyltransferases.

T Bülter1, T Schumacher, D J Namdjou, R Gutiérrez Gallego, H Clausen, L Elling.   

Abstract

The enzymatic oxidation of uridine 5'-diphospho-alpha-D-galactose (UDP-Gal) and uridine 5'-diphospho-N-acetyl-alpha-D-galactosamine (UDP-GalNAc) with galactose oxidase was combined with a chemical biotinylation step involving biotin-epsilon-amidocaproylhydrazide in a one-pot synthesis. The novel nucleotide sugar derivatives uridine 5'-diphospho-6-biotin-epsilon-amidocaproylhydrazino-alpha-D-galactose (UDP-6-biotinyl-Gal) and uridine 5'-diphospho-6-biotin-epsilon-amidocaproylhydrazino-N-acetyl-alpha-D-galactosamine (UDP-6-biotinyl-GalNAc) were synthesized on a 100-mg scale and characterized by mass spectrometry (fast atom bombardment and matrix-assisted laser desorption/ionization time of flight) and one/two dimensional NMR spectroscopy. It could be demonstrated for the first time, by use of UDP-6-biotinyl-Gal as a donor substrate, that the human recombinant galactosyltransferases beta3Gal-T5, beta4Gal-T1, and beta4Gal-T4 mediate biotinylation of the neoglycoconjugate bovine serum albumin-p-aminophenyl N-acetyl-beta-D-glucosaminide (BSA-(GlcNAc)17) and ovalbumin. The detection of the biotin tag transferred by beta3Gal-T5 onto BSA-(GlcNAc)17 with streptavidin-enzyme conjugates gave detection limits of 150 pmol of tagged GlcNAc in a Western blot analysis and 1 pmol of tagged GlcNAc in a microtiter plate assay. The degree of Gal-biotin tag transfer onto agalactosylated hybrid N-glycans present at the single glycosylation site of ovalbumin was dependent on the Gal-T used (either beta3Gal-T5, beta4Gal-T4, or beta4Gal-T1), which indicates that the acceptor specificity may direct the transfer of the Gal-biotin tag. The potential of this biotinylated UDP-Gal as a novel donor substrate for human galactosyltransferases lies in the targeting of distinct acceptor structures, for example, under-galactosylated glycoconjugates, which are related to diseases, or in the quality control of glycosylation of recombinant and native glycoproteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11948877     DOI: 10.1002/1439-7633(20011203)2:12<884::AID-CBIC884>3.0.CO;2-2

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  5 in total

1.  Enzymatic glycan remodeling-metal free click (GlycoConnect™) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineering.

Authors:  Marloes A Wijdeven; Remon van Geel; Jorin H Hoogenboom; Jorge M M Verkade; Brian M G Janssen; Inge Hurkmans; Laureen de Bever; Sander S van Berkel; Floris L van Delft
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

2.  Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-LacNAc) structures and their characterization for CGL2-galectin-mediated binding of ECM glycoproteins to biomaterial surfaces.

Authors:  Birgit Sauerzapfe; Karel Krenek; Judith Schmiedel; Warren W Wakarchuk; Helena Pelantová; Vladimir Kren; Lothar Elling
Journal:  Glycoconj J       Date:  2008-08-29       Impact factor: 2.916

3.  Chemo-enzymatic modification of poly-N-acetyllactosamine (LacNAc) oligomers and N,N-diacetyllactosamine (LacDiNAc) based on galactose oxidase treatment.

Authors:  Christiane E Kupper; Ruben R Rosencrantz; Birgit Henßen; Helena Pelantová; Stephan Thönes; Anna Drozdová; Vladimir Křen; Lothar Elling
Journal:  Beilstein J Org Chem       Date:  2012-05-09       Impact factor: 2.883

Review 4.  The substrate tolerance of alcohol oxidases.

Authors:  Mathias Pickl; Michael Fuchs; Silvia M Glueck; Kurt Faber
Journal:  Appl Microbiol Biotechnol       Date:  2015-07-08       Impact factor: 4.813

5.  Enzymatic desymmetrising redox reactions for the asymmetric synthesis of biaryl atropisomers.

Authors:  Samantha Staniland; Bo Yuan; Nelson Giménez-Agulló; Tommaso Marcelli; Simon C Willies; Damian M Grainger; Nicholas J Turner; Jonathan Clayden
Journal:  Chemistry       Date:  2014-08-22       Impact factor: 5.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.